Get the Stockscreener App
0.4404
0.09%
0.0004
After Hours:
.46
0.0196
+4.45%
Ainos Inc stock is traded at $0.4404, with a volume of 40,951.
It is up +0.09% in the last 24 hours and down -10.67% over the past month.
Ainos Inc is engaged in developing biologics for the treatment of human and animal diseases. The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon-alpha that is administered in a proprietary low-dose oral form. Its product pipeline includes VELDONA Pet cytoprotein supplements for pets, VELDONA human therapeutics for clinical use, and telehealth-friendly POCTs powered by the AI Nose technology platform.
See More
Previous Close:
$0.44
Open:
$0.44
24h Volume:
40,951
Relative Volume:
0.06
Market Cap:
$3.53M
Revenue:
$122.10K
Net Income/Loss:
$-13.77M
P/E Ratio:
-0.5795
EPS:
-0.76
Net Cash Flow:
$-4.79M
1W Performance:
-12.76%
1M Performance:
-10.67%
6M Performance:
-56.40%
1Y Performance:
-25.98%
1-Day Range:
$0.425
$0.4573
1-Week Range:
$0.401
$0.524
52-Week Range:
$0.401
$4.2899
Ainos Inc Stock (AIMD) Company Profile
Name
Ainos Inc
Sector
Industry
Phone
858-869-2986
Address
AINOS, INC., SAN DIEGO
Ainos Inc Stock (AIMD) Latest News
Ainos stock plunges to 52-week low of $0.45 amid steep annual decline - Investing.com
Analyzing CONMED (NYSE:CNMD) & Ainos (OTCMKTS:AIMD) - Defense World
Ainos, Inc. (NASDAQ:AIMD) Short Interest Down 37.6% in October - Defense World
Ainos Expands Patent Portfolio With Strategic Shareholder’s Cutting-Edge Technology Assets - StockTitan
Ainos Highlights VELDONA Clinical Advancements and Market Potential in Water Tower Research Spotlight Podcast - StockTitan
Ainos Inc. secures exclusive patent rights in new deal - Investing.com
Ainos Inc. secures exclusive patent rights in new deal By Investing.com - Investing.com UK
Ainos (OTCMKTS:AIMD) Stock Price Down 8.7% – Here’s Why - Defense World
Ainos Leverages AI Nose for Safer, Smarter Factories - MSN
Financial Health Report: Ainos Inc (AIMD)’s Ratios Tell a Tale - The Dwinnex
Cutera (CUTR) Stock Drops 5.14% Amid Financial Challenges - GuruFocus.com
Ainos Inc. secures stockholder nod for special stock awards - Investing.com
AIMDWAinos, Inc. Warrants Latest Stock News & Market Updates - StockTitan
Ainos Inc (AIMD) Stock: A Year of Highs and Lows - The InvestChronicle
Ainos receives IRB nod for HIV-related oral wart trial - Investing.com India
Ainos, Inc. Receives IRB Approval From National Taiwan University Hospital for HIV-Oral Warts Clinical Trial, Highlighting Value of FDA-Designated Orphan Drug VELDONA - StockTitan
Ainos Spotlighted in Water Tower Research Report on VELDONA Clinical Study for Sjogren’s Syndrome - StockTitan
Ainos Announced Plan to Initiate Taiwan Clinical Study of VELDONA for Treating Sjögren's Syndrome, a Rare Disease With Limited Treatment Options - StockTitan
Esperion Therapeutics (NASDAQ:ESPR) versus Ainos (NASDAQ:AIMD) Critical Analysis - Defense World
Water Tower Research Highlights Ainos VELDONA Clinical Trial for HIV+ Patients with Oral Warts - StockTitan
AIMD stock touches 52-week low at $0.45 amid market challenges - Investing.com
Ainos set for clinical trial of HIV treatment at Taiwan hospital - Investing.com
AIMDAinos, Inc. Latest Stock News & Market Updates - StockTitan
Ainos Announced Plan to Initiate Taiwan Clinical Study for VELDONA as Potential Treatment of Oral Warts in HIV-Seropositive Patients, an Orphan Drug Designated by the FDA - StockTitan
Financial Review: Ainos (OTCMKTS:AIMD) versus Siemens Healthineers (OTCMKTS:SMMNY) - Defense World
Ainos (NASDAQ:AIMD) Shares Down 6.6% - Defense World
Ainos secures Taiwan patent for antiviral drug VELDONA - Investing.com
Ainos Secures Taiwan Invention Patent and Advances Global Patent Protection for VELDONA, a Breakthrough in Coronavirus Treatment and Prevention - Lelezard
Ainos to Participate in H.C. Wainwright 26th Annual Global Investment Conference - StockTitan
Ainos (OTCMKTS:AIMD) Stock Price Up 6.1% - Defense World
Ainos CEO Highlights AI Nose Achievements and Upcoming 2H 2024 Milestones in Shareholder Letter - PharmiWeb.com
Ainos Inc (AIMD) Stock: A Year of Highs and Lows in the Market - The InvestChronicle
Is the Ainos Inc (NASDAQ:AIMD) stock an investment opportunity? - US Post News
Ainos AI Nose achieves 79% accuracy in VOC detection - Investing.com India
Ainos Unveils AI Nose Breakthrough that Revolutionizes Smart Manufacturing Factory Automation and Manufacturing Safety - AccessWire
Ainos Unveils AI Nose Breakthrough that Revolutionizes - GlobeNewswire
Ainos reports 79% identification accuracy of AI Nose - TipRanks
Ainos, Inc. (NASDAQ:AIMD) Short Interest Update - Defense World
CXApp Inc [CXAI] moved down -25.76: Why It’s Important - The DBT News
Check out these key findings about Ainos Inc (AIMD) - SETE News
AIMD’s Stock Market Adventure: -70.20% YTD Growth Amidst Volatility - The InvestChronicle
AIMD’s price-to-book ratio: An indicator of the company’s performance - US Post News
Quarterly Metrics: Quick and Current Ratios for Ainos Inc (AIMD) - The Dwinnex
Why Is Ainos (AIMD) Stock Up 38% Today? - InvestorPlace
Ainos to Participate in Fireside Chat with Water Tower Research on August 22, 2024 - WICZ
Why Ainos Shares Are Trading Higher By Around 38%; Here Are 20 Stocks Moving Premarket - Benzinga
Ainos acquires licences for ten patents to improve point-of-care testing - Yahoo Finance
Guangdong Baolihua New Energy Stock Co., Ltd. (000690.SZ) Latest Stock News & Headlines - Yahoo Finance
Ainos secures exclusive rights to 10 patents in healthcare tech - Investing.com India
Ainos Secures Tech Boost, Expands Portfolio and Settles Debt - TipRanks
Ainos secures exclusive rights to 10 patents in healthcare tech By Investing.com - Investing.com UK
Ainos Inc Stock (AIMD) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.47%
1.00%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):